The post-Covid euphoria surrounding direct equity investing has ebbed in 2025. Individual investors have turned net sellers in the domestic equity market, pulling out about Rs 8,461 crore so far......
Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US — their largest export market — have weighed heavily on investor sentiment this year. Photograph: Amit......
'The long-term impact of elections is minimal.' Illustration: Dominic Xavier/Rediff.com "India's robust fundamentals, reasonable valuations, and strong domestic investment flows provide a buffer,......
Indian engineering research and development (ER&D) players, such as Tata Technologies, Tata Elxsi, and Cyient, among others, had a subdued January-March quarter of 2023-24. Photograph: Dan......
The Indian cement industry is hopeful of greener pastures after a long period of stress led by pricing pressures and other factors. Photograph: Anindito Mukherjee/Reuters The second half of FY25......